Trials / Completed
CompletedNCT02278354
Tau Imaging in Professional Fighters
18F-AV-1451 PET Imaging in Professional Fighters
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | IV injection, 370 megabecquerel (MBq) (10 mCi) |
| PROCEDURE | Brain PET scan | positron emission tomography (PET) scan of the brain 75-105 minutes post injection |
Timeline
- Start date
- 2015-02-18
- Primary completion
- 2017-02-03
- Completion
- 2017-02-03
- First posted
- 2014-10-30
- Last updated
- 2020-09-10
- Results posted
- 2020-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02278354. Inclusion in this directory is not an endorsement.